Joao Lima, MD
Cardiovascular Disease · Baltimore, MDNPI 1396789319
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (58.2%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Canon Medical Systems Corporation at 48.8% of the total. Reporting peaked in 2024 at $32,534 and has fallen 95.2% since, to $1,564 in 2025. Among cardiovascular disease clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 35 payments — averaging $1916.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Canon Medical Systems Corporation$33K
- Astrazeneca UK Limited$14K
- Astrazeneca AB$14K
- Sanofi-aventis U.S. LLC$3K
- Guerbet LLC$1K
- Regeneron$1K
- plus $633 from 3 others
Across 34 payments — averaging $161,914 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Astrazeneca UK Limited$4.1M
- AstraZeneca$1.4M
- Guerbet LLC$42K
What the payments were for
- Consulting fees$20,04030%
- Speaking & faculty fees$6,54010%
- Travel & lodging$39,06658%
- Food & beverage$1,4142%
- Gifts$240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Canon Medical Systems Corporation | 8 | $32,715 |
| Astrazeneca UK Limited | 2 | $14,079 |
| Astrazeneca AB | 11 | $13,983 |
| Sanofi-aventis U.S. LLC | 1 | $2,864 |
| Guerbet LLC | 5 | $1,458 |
| Regeneron | 3 | $1,352 |
| Canon Healthcare USA, Inc. | 3 | $551 |
| Canon Medical Systems USA, Inc. | 1 | $59 |
| Canon Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Vantage Galan 3T MRT-3020$4,040
- MULTAQ$2,864
- ELUCIREM$1,458
- Aquilion INSIGHT TSX-308A$568
How this compares
$67,083 in reported general payments places this provider in the 95th percentile of 507 cardiovascular disease providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Baltimore
- Navin KapurBaltimore$1.5M
- Michael BlahaBaltimore$609K
- Sanjay RajagopalanBaltimore$521K
- Erin MichosBaltimore$257K
- Seth MartinBaltimore$166K
- Erika FellerBaltimore$121K
- Charles CummingsBaltimore$114K
- John RickardBaltimore$109K
- Christopher DefilippiBaltimore$101K
- David KassBaltimore$90K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.